Atropine vs Isoprenaline in the Invasive Diagnosis of Arrhythmias

• Status: Not yet recruiting
• Trial end date: 2025-12-01
• Target enrollment: 0
• Participant gender: All

Summary

During electrophysiological study (EPS) multiple drugs are used to reveal arrhythmias and/or conductive system disorders. Two most often used agents are atropine and isoprenaline. Due to their distinct pharmacological properties, they are affecting myocardium in different manner. Those dissimilarities can affect the EPS course and long-term prognosis. The aim of presented study is to evaluate the optimal protocol of pharmacotherapy during EPS.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical University of Lodz
• Treatments: Atropine; Isoproterenol

Criteria

Inclusion Criteria:

• Patients with indication for electrophysiological study according to present guidelines of European Society of Cardiology

Exclusion Criteria:

• Not willing or incapable to give written informed consent.

• Previous diagnosed ventricle tachycardia or fibrillation

• Previous diagnosed atrial fibrillation or flutter

• Glaucoma (contraindication for atropine)